FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplantation (HCT) is associated with high mortality. Purpose: We hypothesized that FAM (inhaled Fluticasone, Azithromycin, and Montelukast) with a brief steroid pulse could avert progression of new-onset BOS. Experimenta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biol Blood Marrow Transplant
Egile Nagusiak: Williams, Kirsten M., Cheng, Guang-Shing, Pusic, Iskra, Jagasia, Madan, Burns, Linda, Ho, Vincent T., Pidala, Joseph, Palmer, Jeanne, Johnston, Laura, Mayer, Sebastian, Chien, Jason W., Jacobsohn, David A., Pavletic, Steven Z., Martin, Paul J., Storer, Barry E., Inamoto, Yoshihiro, Chai, Xiaoyu, Flowers, Mary E.D., Lee, Stephanie J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801753/
https://ncbi.nlm.nih.gov/pubmed/26475726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.10.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak